2R8S image
Deposition Date 2007-09-11
Release Date 2007-12-04
Last Version Date 2024-10-30
Entry Detail
PDB ID:
2R8S
Title:
High resolution structure of a specific synthetic FAB bound to P4-P6 RNA ribozyme domain
Biological Source:
Source Organism:
(Taxon ID: )Mus musculus (Taxon ID: 10090)
Method Details:
Experimental Method:
Resolution:
1.95 Å
R-Value Free:
0.22
R-Value Work:
0.19
R-Value Observed:
0.19
Space Group:
C 1 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Fab heavy chain
Chain IDs:C (auth: H)
Chain Length:224
Number of Molecules:1
Biological Source:Mus musculus
Polymer Type:polypeptide(L)
Molecule:Fab light chain
Chain IDs:B (auth: L)
Chain Length:214
Number of Molecules:1
Biological Source:Mus musculus
Polymer Type:polyribonucleotide
Molecule:P4-P6 RNA RIBOZYME DOMAIN
Mutations:Delta C209
Chain IDs:A (auth: R)
Chain Length:159
Number of Molecules:1
Biological Source:
Ligand Molecules
Primary Citation
Synthetic antibodies for specific recognition and crystallization of structured RNA
Proc.Natl.Acad.Sci.Usa 105 82 87 (2008)
PMID: 18162543 DOI: 10.1073/pnas.0709082105

Abstact

Antibodies that bind protein antigens are indispensable in biochemical research and modern medicine. However, knowledge of RNA-binding antibodies and their application in the ever-growing RNA field is lacking. Here we have developed a robust approach using a synthetic phage-display library to select specific antigen-binding fragments (Fabs) targeting a large functional RNA. We have solved the crystal structure of the first Fab-RNA complex at 1.95 A. Capability in phasing and crystal contact formation suggests that the Fab provides a potentially valuable crystal chaperone for RNA. The crystal structure reveals that the Fab achieves specific RNA binding on a shallow surface with complementarity-determining region (CDR) sequence diversity, length variability, and main-chain conformational plasticity. The Fab-RNA interface also differs significantly from Fab-protein interfaces in amino acid composition and light-chain participation. These findings yield valuable insights for engineering of Fabs as RNA-binding modules and facilitate further development of Fabs as possible therapeutic drugs and biochemical tools to explore RNA biology.

Legend

Protein

Chemical

Disease

Primary Citation of related structures